Xanomeline
Xanomeline, a cholinergic agonist, was initially evaluated for the treatment of Alzheimer’s disease and schizophrenia. Reference standards of Xanomeline API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => 3-(4-(Hexyloxy)-1,2,5-thiadiazol-3-yl)-1-isopropylpyridin-1-ium Chloride
[catalogue_number] => PA 24 0111012
[category_ids] => ,82,78,76,75,70,
[chemical_name] =>
[weight] => 341.9
[form] => C16H24ClN3OS
[cas] => NA
[pslug] => 3-4-hexyloxy-1-2-5-thiadiazol-3-yl-1-isopropylpyridin-1-ium-chloride-pa240111012
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
3-(4-(Hexyloxy)-1,2,5-thiadiazol-3-yl)-1-isopropylpyridin-1-ium Chloride
stdClass Object
(
[pname] => 3-(4-Isopropoxy-1,2,5-thiadiazol-3-yl)-1-isopropylpyridin-1-ium Chloride
[catalogue_number] => PA 24 0111013
[category_ids] => ,82,78,76,75,70,
[chemical_name] =>
[weight] => 299.82
[form] => C13H18ClN3OS
[cas] => NA
[pslug] => 3-4-isopropoxy-1-2-5-thiadiazol-3-yl-1-isopropylpyridin-1-ium-chloride-pa240111013
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
3-(4-Isopropoxy-1,2,5-thiadiazol-3-yl)-1-isopropylpyridin-1-ium Chloride
Catalogue No.:PA 24 0111013
Molecular Formula : C13H18ClN3OS
Molecular Weight : 299.82
